Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Critical Care
Literature
1.
Benítez-Cano A, Luque S, Sorlí L, Carazo J, Ramos I, Campillo N, Curull V, Sánchez-Font A, Vilaplana C, Horcajada JP, Adalia R, Bermejo S, Samsó E, Hope W, Grau S. Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial. Crit Care. 2020;24:55.CrossRef
2.
Boselli E, Breilh D, Rimmelé T, Guillaume C, Xuereb F, Saux MC, Bouvet L, Chassard D, Allaouchiche B. Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia. Crit Care Med. 2008;36:1500–6.CrossRef
3.
Heffernan AJ, Sime FB, Lipman J, Dhanani J, Andrews K, Ellwood D, Grimwood K, Roberts JA. Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: a systematic review. Int J Antimicrob Agents. 2019;53:234–45.CrossRef
4.
Frippiat F, Musuamba FT, Seidel L, Albert A, Denooz R, Charlier C, Van Bambeke F, Wallemacq P, Descy J, Lambermont B, Layios N, Damas P, Moutschen M. Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study. J Antimicrob Chemother. 2015;70:207–16.CrossRef
5.
Delattre IK, Briquet C, Wallemacq P, Tulkens PM, Van Bambeke F. Comparative in vitro antimicrobial potency, stability, colouration and dissolution time of generics versus innovator of meropenem in Europe. Int J Antimicrob Agents. 2020;55:105825.CrossRef
Metadata
Title
Meropenem: continuous or extended infusion?
Authors
Frédéric Frippiat
Christelle Vercheval
Nathalie Layios
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2020
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-020-02883-w

Other articles of this Issue 1/2020

Critical Care 1/2020 Go to the issue

Research Letter

Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series

Research

Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis

Research

Electrical impedance tomography to titrate positive end-expiratory pressure in COVID-19 acute respiratory distress syndrome

Research Letter

Safe doubling of ventilator capacity: a last resort proposal for last resorts

Research

Duration of antibiotic therapy in critically ill patients: a randomized controlled trial of a clinical and C-reactive protein-based protocol versus an evidence-based best practice strategy without biomarkers

Research Letter

Three-step checklist for tracheostomy in critically ill COVID-19 patients